MHRA Seeks Views on ‘No-Deal’ Brexit Legislation and Procedural ChangesAllbiopro2018-10-07T12:39:24+09:0010월 7th, 2018|
HIV Treatments That Could Make Redfield’s Prediction a Reality to Defeat AIDS EpidemicAllbiopro2018-10-05T08:50:40+09:0010월 5th, 2018|
Arrowhead Goes All in With J&J to Develop Hep B Drug for $3.7BAllbiopro2018-10-05T08:50:13+09:0010월 5th, 2018|
Boehringer and Lilly’s Jardiance Looks Good for Type I DiabetesAllbiopro2018-10-05T08:49:46+09:0010월 5th, 2018|
Bayer Cutting More Than 200 Jobs in San Francisco Bay AreaAllbiopro2018-10-05T08:49:20+09:0010월 5th, 2018|
It’s Flu Season! Genentech’s Investigational Medicine Continues to Show EfficacyAllbiopro2018-10-05T08:48:55+09:0010월 5th, 2018|
In Small Patient Group, Sarepta’s DMD Gene Therapy Gives Some HopeAllbiopro2018-10-05T08:48:01+09:0010월 5th, 2018|
Technology Is Revolutionizing Clinical Trials: Here’s HowAllbiopro2018-10-05T08:47:10+09:0010월 5th, 2018|
It Seems Counterintuitive, but Inspirational Bosses Can Sometimes Harm Employees’ HealthAllbiopro2018-10-05T08:46:44+09:0010월 5th, 2018|
Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-ThalassemiaAllbiopro2018-10-05T08:46:17+09:0010월 5th, 2018|
MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced InflammationAllbiopro2018-10-05T08:45:47+09:0010월 5th, 2018|
Want a glimpse into pharma’s future? Look to cable television, Merck CEO saysAllbiopro2018-10-05T08:45:20+09:0010월 5th, 2018|
Disgruntled Takeda alumni demand a window into $62B Shire buyAllbiopro2018-10-05T08:44:54+09:0010월 5th, 2018|
BIO’s ultimatum to members: Get serious about gender diversity or face our furyAllbiopro2018-10-05T08:44:28+09:0010월 5th, 2018|
One way to thwart generics delays? Look skeptically at citizen petitions, FDA saysAllbiopro2018-10-05T08:44:02+09:0010월 5th, 2018|
As Jivi launches, Bayer cuts 227 workers at U.S. plant that produces hemophilia treatmentAllbiopro2018-10-05T08:43:36+09:0010월 5th, 2018|
EuroBiotech Report—Roche inks cancer deals, Forbion’s €360M fund, U.K. VC soars and GamidaAllbiopro2018-10-05T08:43:10+09:0010월 5th, 2018|
